Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2014, Article ID 470452, 7 pages
http://dx.doi.org/10.1155/2014/470452
Research Article

Research on the Interaction between Tubeimoside 1 and HepG2 Cells Using the Microscopic Imaging and Fluorescent Spectra Method

Key Laboratory of Optoelectronic Technology and Systems of Ministry of Education of China, Chongqing University, Chongqing 400044, China

Received 18 March 2014; Accepted 26 April 2014; Published 14 May 2014

Academic Editor: Peng Feng

Copyright © 2014 Xiaogang Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Yang, T. X. Yu, R. D. Ma et al., “Cell cycle arrest and apoptosis induced by tubeimoside in HeLa cell,” Chinese Journal of Cancer, vol. 21, no. 4, pp. 346–350, 2002. View at Google Scholar · View at Scopus
  2. J. V. Pergolizzi Jr., M. Auster, G. L. Conaway, and A. Sardi, “Cryosurgery for unresectable primary hepatocellular carcinoma: a case report and review of literature,” American Surgeon, vol. 65, no. 5, pp. 402–405, 1999. View at Google Scholar · View at Scopus
  3. J. Yamamoto, T. Kosuge, T. Takayama et al., “Recurrence of hepatocellular carcinoma after surgery,” British Journal of Surgery, vol. 83, no. 9, pp. 1219–1222, 1996. View at Publisher · View at Google Scholar
  4. C. Parlak, E. Topkan, S. Sonmez, C. Onal, and M. Reyhan, “CT-versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison,” Japanese Journal of Radiolgy, vol. 30, no. 8, pp. 628–634, 2012. View at Publisher · View at Google Scholar
  5. B. Lambert, H. van Vlierberghe, R. Troisi, and L. Defreyne, “Radionuclide therapy for hepatocellular carcinoma,” Acta Gastro-Enterologica Belgica, vol. 73, no. 4, pp. 484–488, 2010. View at Google Scholar · View at Scopus
  6. M. B. Thomas and A. X. Zhu, “Hepatocellular carcinoma: the need for progress,” Journal of Clinical Oncology, vol. 23, no. 13, pp. 2892–2899, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. Thomas, “Systemic therapy for hepatocellular carcinoma,” Cancer Journal, vol. 14, no. 2, pp. 123–127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. N. Wills, W. M. Huang, M. P. Harris, T. Machemer, D. C. Maneval, and R. J. Gregory, “Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene,” Cancer Gene Therapy, vol. 2, no. 3, pp. 191–197, 1995. View at Google Scholar · View at Scopus
  9. T. R. Golub, D. K. Slonim, P. Tamayo et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, vol. 286, no. 5439, pp. 531–537, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Nair, A. Heiser, D. Boczkowski et al., “Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells,” Nature Medicine, vol. 6, no. 9, pp. 1011–1017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. F. McCormick, “Cancer gene therapy: fringe or cutting edge?” Nature Reviews Cancer, vol. 1, no. 2, pp. 130–141, 2001. View at Google Scholar · View at Scopus
  12. Z. Darzynkiewicz, F. Traganos, J. M. Wu, and S. Chen, “Chinese herbal mixture PC SPES in treatment of prostate cancer (review),” International Journal of Oncology, vol. 17, no. 4, pp. 729–736, 2000. View at Google Scholar · View at Scopus
  13. F. Qi, A. Li, Y. Inagaki et al., “Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer,” Bioscience Trends, vol. 4, no. 6, pp. 297–307, 2010. View at Google Scholar · View at Scopus
  14. E. Chan, M. Tan, J. Xin, S. Sudarsanam, and D. E. Johnson, “Interactions between traditional Chinese medicines and Western therapeutics,” Current Opinion in Drug Discovery and Development, vol. 13, no. 1, pp. 50–65, 2010. View at Google Scholar · View at Scopus
  15. W. J. Ruan, M. D. Lai, and J. G. Zhou, “Anticancer effects of Chinese herbal medicine, science or myth?” Journal of Zhejiang University: Science B, vol. 7, no. 12, pp. 1006–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. S. Parmar, Y. Dixit, and A. Kar, “Fruit and vegetable peels: paving the way towards the development of newgeneration therapeutics,” Drug Discoveries & Therapeutics, vol. 4, no. 5, pp. 314–325, 2010. View at Google Scholar
  17. H. Ouyang, P. Wang, Z. Meng et al., “Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine,” Pancreas, vol. 40, no. 1, pp. 120–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Lin, R. Wang, Y. Guo, C. Gao, and X. Guo, “Comparative study of light scattering from hepatoma cells and hepatocytes,” International Journal of Thermophysics, vol. 33, no. 10-11, pp. 1795–1800, 2012. View at Publisher · View at Google Scholar
  19. Y. Xu, Y. P. Ching, Y. Zhou, J. F. Chiu, F. Chen, and Q. Y. He, “Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells,” Journal of Proteomics, vol. 75, no. 2, pp. 491–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Ma, L. Yu, and W. Su, “Induction of cell cycle arrest and apoptosis by tubeimoside 1 isolated from Bolbostemmapaniculatum in Hela cells,” Chinese Journal of Clinic Pharmacology and Therapeutics, vol. 9, pp. 261–269, 2004. View at Google Scholar
  21. L. Yu, R. Ma, and T. Yu, “Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by tubeimoside 1,” Planta Medica, vol. 62, pp. 119–121, 1996. View at Google Scholar
  22. X. Lin, Y. Pan, and Y. Guo, “Study on autofluorescence spectral feature for cancer cell in different stages of cell cycle,” Acta Optica Sinica, vol. 29, no. 5, pp. 1328–1331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Sułkowska, “Interaction of drugs with bovine and human serum albumin,” Journal of Molecular Structure, vol. 614, no. 1-3, pp. 227–232, 2002. View at Publisher · View at Google Scholar · View at Scopus